Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPaNIC: Early vs Late Parenteral Nutrition in Critically Ill Adults
NCT00512122Phase 4Active, not recruiting
- Sponsor
- KU Leuven
- Start
- Aug 2007
- Primary completion
- Feb 2011
- Modality
- Recombinant Proteins and Enzymes, Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 4 trial of Oliclinomel in critical illness, Starvation, sponsored by KU Leuven. Started Aug 2007; status: active, not recruiting.
02
Drugs
Oliclinomel
03
Conditions
critical illnessStarvation
Beyond the preview
Go deeper on NCT00512122.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00512122.